The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial.
Andres J.M. Ferreri
No relevant relationships to disclose
Giovanni Donadoni
No relevant relationships to disclose
Maria Giuseppina Cabras
No relevant relationships to disclose
Caterina Patti
No relevant relationships to disclose
Michael Mian
No relevant relationships to disclose
Renato Zambello
No relevant relationships to disclose
Corrado Tarella
No relevant relationships to disclose
Massimo A. Di Nicola
No relevant relationships to disclose
Alfonso D'Arco
No relevant relationships to disclose
Marta Bruno Ventre
No relevant relationships to disclose
Marco Foppoli
No relevant relationships to disclose
Alessandro Fanni
No relevant relationships to disclose
Gianluca Doa
No relevant relationships to disclose
Antonio Mulè
No relevant relationships to disclose
Federico Caligaris-Cappio
No relevant relationships to disclose
Fabio Ciceri
No relevant relationships to disclose